Clinical RoundupFree NCI-MATCH has 12 open arms awaiting patients with advanced or rare cancers May 07, 2021Vol.47 No.18
Clinical RoundupFree NCCN releases new patient guidelines on anemia and neutropenia May 07, 2021Vol.47 No.18
Clinical RoundupFree UNC researchers examine approaches to deliver radiation to tumors while sparing healthy tissue May 07, 2021Vol.47 No.18
Clinical RoundupFree City of Hope opens phase II clinical trial to test if intake of mushroom-powder tablets could slow the progression of prostate cancer May 07, 2021Vol.47 No.18
Drugs & TargetsFree Keytruda receives FDA Accelerated Approval for HER2-positive gastric cancer May 07, 2021Vol.47 No.18
Drugs & TargetsFree Tibsovo sNDA receives FDA acceptance and Priority Review for IDH1-mutated cholangiocarcinoma May 07, 2021Vol.47 No.18
Drugs & TargetsFree Opdivo sBLA receives FDA acceptance and Priority Review for adjuvant treatment for patients with muscle-invasive urothelial carcinoma May 07, 2021Vol.47 No.18
Drugs & TargetsFree Xtandi approved by European Commission for men with metastatic hormone-sensitive prostate cancer May 07, 2021Vol.47 No.18
Drugs & TargetsFree Janssen submits Marketing Authorization Application to EMA seeking approval of cilta-cel for relapsed and/or refractory multiple myeloma May 07, 2021Vol.47 No.18
